News & Updates
Filter by Specialty:
High CRP level tied to earlier death in ILD
Increased levels of serum C-reactive protein (CRP) may contribute to shorter survival in patients with idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis (fHP), rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), or systemic sclerosis (SSc)-associated ILD at 5 years.
High CRP level tied to earlier death in ILD
07 Mar 2024
Abatacept may mitigate rheumatoid arthritis development in at-risk individuals
The use of abatacept in adults at high risk of rheumatoid arthritis helps protect against disease onset, as shown in the phase IIB APIPPRA study.
Abatacept may mitigate rheumatoid arthritis development in at-risk individuals
23 Feb 2024
Serious infections prevalent in RTX-treated patients with SLE
A recent study has reported the prevalence of serious infection (SI) among patients with systemic lupus erythematosus (SLE) following treatment with rituximab (RTX).
Serious infections prevalent in RTX-treated patients with SLE
13 Feb 2024
Is BASDAI a responsive instrument in PsA?
Use of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) as an instrument in psoriatic arthritis (PsA) demonstrates “reasonable” responsiveness but falls short of distinguishing peripheral PsA from axial (ax)PsA, according to a recent study.
Is BASDAI a responsive instrument in PsA?
13 Feb 2024
Sarawak General Hospital's Clinical Research Centre is the first site in the Asia-Pacific region for first-in-human clinical trial on new SLE drug
The first-in-human (FIH) trial on a new experimental drug to treat patients with systemic lupus erythematosus (SLE) will be conducted at Sarawak General Hospital (SGH), making it the first research center in the Asia-Pacific region to do so.
